When should Duphaston (dydrogesterone) be started after ovulation is confirmed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Start Duphaston (Dydrogesterone)

Start Duphaston immediately after confirmed ovulation, typically on day 14-16 of the menstrual cycle, or from the day of oocyte retrieval in assisted reproduction cycles.

Timing Based on Clinical Context

For Luteal Phase Support in Natural Cycles

When using dydrogesterone for luteal phase support in women with irregular menstruation or infertility:

  • Begin on days 14-16 of the cycle (post-ovulation)
  • Standard dosing: 10 mg twice daily 1
  • Continue through days 21-26, or until pregnancy test if conception is attempted 1

For Assisted Reproductive Technology (ART)

In IVF/ICSI cycles, the timing is more precisely defined:

  • Start on day 0 (day of oocyte retrieval) 2
  • Dosing: 10 mg twice daily (20 mg total daily dose)
  • Continue until pregnancy test, or if pregnant, until week 10 of gestation 2
  • This approach achieved comparable ongoing pregnancy rates (30.3%) to vaginal progesterone 2

For Prevention of Recurrent Miscarriage

When used for women with history of recurrent pregnancy loss:

  • Begin immediately after ovulation is confirmed 3
  • Dosing: 20 mg daily
  • Continue throughout the first trimester 3

Important Clinical Considerations

Ovulation Confirmation is Critical: Do not start dydrogesterone before confirming ovulation has occurred, as it can suppress the mid-cycle gonadotropin surge and potentially prevent ovulation 4. When given before ovulation, dydrogesterone either abolished or markedly diminished the LH surge in all subjects studied.

Post-Ovulation Window: The medication should be initiated within 24-48 hours after ovulation confirmation to provide optimal luteal phase support. Waiting longer may compromise endometrial preparation.

Duration Considerations:

  • For cycle regulation: Days 14-26 of cycle 1
  • For ART luteal support: Day of retrieval through week 10 if pregnant 2
  • For threatened miscarriage: Throughout first trimester 5

Practical Algorithm

  1. Confirm ovulation via:

    • Ultrasound showing collapsed follicle
    • LH surge detection (urine or serum)
    • Basal body temperature rise
    • Serum progesterone elevation
  2. Initiate dydrogesterone within 24-48 hours of confirmed ovulation

  3. Choose dosing regimen:

    • Standard: 10 mg BID (20 mg daily)
    • Higher dose if needed: 30 mg daily 6, 7
    • Once-daily sustained release formulations available 5
  4. Continue until:

    • Menstruation (if not pregnant)
    • Pregnancy test (if attempting conception)
    • Week 10 of pregnancy (if pregnant in ART cycles)

The evidence consistently demonstrates that oral dydrogesterone provides effective luteal support with high patient satisfaction and compliance compared to vaginal progesterone formulations 2, 6, 7, making proper timing of initiation essential for optimal outcomes.

References

Research

Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.

European journal of obstetrics, gynecology, and reproductive biology, 2015

Research

Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.